首页> 外文期刊>Dermatologic surgery >Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold.
【24h】

Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold.

机译:用可变脉冲高通量脉冲染料激光治疗面部毛细血管扩张:疗效与紫癜阈值上下的注量进行比较。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND. : Pulsed-dye laser treatment has been shown to be highly effective for the treatment of facial telangiectasia. Posttreatment purpura after such treatment has limited patient acceptance of the procedure. OBJECTIVE. : To determine whether purpura-free treatment with recently introduced variable-pulsed pulsed-dye lasers can effectively reduce facial telangiectasia. METHODS. : This was a prospective, randomized, controlled, nonblinded trial. Eleven patients received variable-pulse pulsed-dye laser treatment with and without induction of purpura. Telangiectasia were graded on a "telangiectasia density scale," on which a 1 signified extremely fine, sparsely distributed telangiectasia, and 5 referred to thick, ropelike telangiectasia covering the affected area. For each subject, two areas on either side of the facial midline with equivalent telangiectasia density ratings were randomized to the purpura and purpura-free treatment groups, respectively. All treatments used a 7-mm spot size and a 10-mspulse duration. The fluence associated with the purpura threshold for each patient was determined in test areas. Purpura-free treatment entailed a fluence 1.0 J/cm2 less than the purpura threshold, and purpura-level treatment entailed a fluence 0.5 J/cm2 greater than the threshold. RESULTS. : Six weeks after a single purpura-free treatment, mean telangiectasia ratings were reduced from 2.7 to 2.4. Purpura-level treatments resulted in a decrease to 1.4 from the same baseline. Thicker, denser telangiectasia appeared to benefit more from purpura-level treatment (a mean telangiectasia density scale reduction of 1.7) than finer, sparser telangiectasia (a mean reduction of 0.8). In 81% of cases, both investigators and patients rated the side treated with purpura as undergoing a greater reduction in telangiectasia density. CONCLUSION. : Although facial telangiectasia do improve after a single purpura-free treatment with the variable-pulse pulsed-dye laser, they improve more after purpura is induced. Purpura-free andpurpura-level treatments may be close to equivalent for treating fine telangiectasia, but purpura-level treatments have a distinct advantage for treating thicker telangiectasia. Significantly, the variable-pulse pulsed-dye laser offers patients the option of effective treatment of some telangiectasia without bruising.
机译:背景。 :脉冲染料激光治疗已被证明对于治疗面部毛细血管扩张非常有效。此类治疗后的治疗后紫癜限制了患者对该手术的接受。目的。 :确定最近采用的可变脉冲脉冲染料激光进行的无紫癜治疗是否可以有效减少面部毛细血管扩张。方法。 :这是一项前瞻性,随机,对照,非盲试验。 11例患者接受或不诱发紫癜均接受了可变脉冲脉冲染料激光治疗。毛细血管扩张症按“毛细血管扩张症密度等级”分级,其中1表示极细,稀疏分布的毛细血管扩张症,5表示覆盖患部的粗绳状毛细血管扩张症。对于每位受试者,分别将面部中线两侧具有相等毛细血管扩张密度等级的两个区域随机分为紫癜和无紫癜治疗组。所有处理均使用7毫米的光斑大小和10毫秒的脉冲持续时间。在测试区域确定与每个患者的紫癜阈值相关的通量。无紫癜治疗的通量要比紫癜阈值低1.0 J / cm2,紫癜水平的治疗需要的通量比阈值高0.5 J / cm2。结果。 :单次无紫癜治疗后六周,毛细血管扩张评分从2.7降至2.4。紫癜水平的治疗导致从同一基线降低至1.4。与较细的毛细血管扩张(平均降低0.8)相比,更厚,更密集的毛细血管扩张似乎从紫癜水平治疗(平均毛细血管扩张密度等级降低1.7)中受益更多。在81%的病例中,研究者和患者都将接受紫癜治疗的一侧的毛细血管扩张密度进一步降低。结论。 :尽管使用可变脉冲脉冲染料激光进行单次无紫癜治疗后面部毛细血管扩张确实有所改善,但诱发紫癜后它们的改善更大。无紫癜和紫癜水平的治疗可能接近于治疗细小的毛细血管扩张的等效方法,但是紫癜水平的治疗对于治疗较厚的毛细血管扩张具有明显的优势。重要的是,可变脉冲脉冲染料激光为患者提供了有效治疗某些毛细血管扩张而不会引起瘀伤的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号